
Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience
Author(s) -
Hannah Rinehardt,
Mahmoud Kassem,
Evan Morgan,
Marilly Palettas,
Julie Stephens,
Anupama Suresh,
Akaansha Ganju,
Maryam Lustberg,
Robert Wesolowski,
Sagar Sardesai,
Daniel G. Stover,
Jeffrey VanDeusen,
Mathew Cherian,
Maria del Pilar Guillermo Prieto Eibl,
Abdul Miah,
Iyad Alnahhas,
Pierre Giglio,
Vinay K. Puduvalli,
Bhuvaneswari Ramaswamy,
Nicole Williams,
Anne M. Noonan
Publication year - 2021
Publication title -
meme sağlığı dergisi/meme sağlığı dergisi
Language(s) - English
Resource type - Journals
eISSN - 1306-0953
pISSN - 1306-0945
DOI - 10.4274/ejbh.galenos.2021.2021-4-10
Subject(s) - medicine , meningeal carcinomatosis , breast cancer , stage (stratigraphy) , chemotherapy , retrospective cohort study , lung cancer , cytology , cancer , surgery , radiology , cerebrospinal fluid , pathology , paleontology , biology
Leptomeningeal carcinomatosis (LMC), a common complication of advanced malignancies, is associated with high morbidity and mortality, yet diagnosis and treatment decisions remain challenging. This study describes the diagnostic and treatment modalities for LMC and identifies factors associated with overall survival (OS).